BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29184406)

  • 1. Effect of A-317491 delivered by glycolipid-like polymer micelles on endometriosis pain.
    Yuan M; Ding S; Meng T; Lu B; Shao S; Zhang X; Yuan H; Hu F
    Int J Nanomedicine; 2017; 12():8171-8183. PubMed ID: 29184406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of ATF3/AP-1 signaling pathway is required for P2X3-induced endometriosis pain.
    Ding S; Yu Q; Wang J; Zhu L; Li T; Guo X; Zhang X
    Hum Reprod; 2020 May; 35(5):1130-1144. PubMed ID: 32303740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing Drug Delivery for Overcoming Angiogenesis and Improving the Phototherapy Efficacy of Glioblastoma by ICG-Loaded Glycolipid-Like Micelles.
    Liu Y; Dai S; Wen L; Zhu Y; Tan Y; Qiu G; Meng T; Yu F; Yuan H; Hu F
    Int J Nanomedicine; 2020; 15():2717-2732. PubMed ID: 32368051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic administration of the selective P2X3, P2X2/3 receptor antagonist, A-317491, transiently attenuates cancer-induced bone pain in mice.
    Hansen RR; Nasser A; Falk S; Baldvinsson SB; Ohlsson PH; Bahl JM; Jarvis MF; Ding M; Heegaard AM
    Eur J Pharmacol; 2012 Aug; 688(1-3):27-34. PubMed ID: 22634164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective antitumor gene therapy delivered by polyethylenimine-conjugated stearic acid-g-chitosan oligosaccharide micelles.
    Hu FQ; Chen WW; Zhao MD; Yuan H; Du YZ
    Gene Ther; 2013 Jun; 20(6):597-606. PubMed ID: 22951455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A317491 relieved HIV gp120-associated neuropathic pain involved in P2X
    Yi Z; Rao S; Ouyang S; Bai Y; Yang J; Ma Y; Han X; Wu B; Zou L; Jia T; Zhao S; Hu X; Lei Q; Gao Y; Liu S; Xu H; Zhang C; Liang S; Li G
    Brain Res Bull; 2017 Apr; 130():81-89. PubMed ID: 28065732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of A-317491, a novel and selective P2X3/P2X2/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration.
    McGaraughty S; Wismer CT; Zhu CZ; Mikusa J; Honore P; Chu KL; Lee CH; Faltynek CR; Jarvis MF
    Br J Pharmacol; 2003 Dec; 140(8):1381-8. PubMed ID: 14623769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial alkaline pH-responsive drug release mediated by Celastrol loaded glycolipid-like micelles for cancer therapy.
    Tan Y; Zhu Y; Zhao Y; Wen L; Meng T; Liu X; Yang X; Dai S; Yuan H; Hu F
    Biomaterials; 2018 Feb; 154():169-181. PubMed ID: 29128845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-cycle chemotherapy with the glycolipid-like polymeric micelles evade cancer stem cell enrichment in breast cancer therapy.
    Meng T; Liu J; Wen L; Yuan M; Cheng B; Hu Y; Zhu Y; Liu X; Yuan H; Hu F
    Oncotarget; 2016 Nov; 7(45):72978-72989. PubMed ID: 27659522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade and reversal of spinal morphine tolerance by P2X3 receptor antagonist.
    Ma X; Xu T; Xu H; Jiang W
    Behav Pharmacol; 2015 Apr; 26(3):260-7. PubMed ID: 25350728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy of endometriosis introduced by polymeric micelles with glycolipid-like structure.
    Zhao MD; Sun YM; Fu GF; Du YZ; Chen FY; Yuan H; Zheng CH; Zhang XM; Hu FQ
    Biomaterials; 2012 Jan; 33(2):634-43. PubMed ID: 21996531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous opioid mechanisms partially mediate P2X3/P2X2/3-related antinociception in rat models of inflammatory and chemogenic pain but not neuropathic pain.
    McGaraughty S; Honore P; Wismer CT; Mikusa J; Zhu CZ; McDonald HA; Bianchi B; Faltynek CR; Jarvis MF
    Br J Pharmacol; 2005 Sep; 146(2):180-8. PubMed ID: 16041397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory role of supraspinal P2X3/P2X2/3 subtypes on nociception in rats.
    Fukui M; Nakagawa T; Minami M; Satoh M; Kaneko S
    Mol Pain; 2006 Jun; 2():19. PubMed ID: 16753051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting High Expressed α
    Shao S; Zhu Y; Meng T; Liu Y; Hong Y; Yuan M; Yuan H; Hu F
    Mol Pharm; 2018 Apr; 15(4):1653-1663. PubMed ID: 29533631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibers.
    Davenport AJ; Neagoe I; Bräuer N; Koch M; Rotgeri A; Nagel J; Laux-Biehlmann A; Machet F; Coelho AM; Boyce S; Carty N; Gemkow MJ; Hess SD; Zollner TM; Fischer OM
    Sci Rep; 2021 Oct; 11(1):19877. PubMed ID: 34615939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P2X3 receptor involvement in endometriosis pain via ERK signaling pathway.
    Ding S; Zhu L; Tian Y; Zhu T; Huang X; Zhang X
    PLoS One; 2017; 12(9):e0184647. PubMed ID: 28898282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P2X3 receptors contribute to muscle pain induced by static contraction by a mechanism dependent on neutrophil migration.
    de Melo Aquino B; da Silva Dos Santos DF; Jorge CO; Marques ACS; Teixeira JM; Parada CA; Oliveira-Fusaro MCG
    Purinergic Signal; 2019 Jun; 15(2):167-175. PubMed ID: 31115830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroacupuncture and A-317491 depress the transmission of pain on primary afferent mediated by the P2X3 receptor in rats with chronic neuropathic pain states.
    Wang WS; Tu WZ; Cheng RD; He R; Ruan LH; Zhang L; Gong YS; Fan XF; Hu J; Cheng B; Lai YP; Zou EM; Jiang SH
    J Neurosci Res; 2014 Dec; 92(12):1703-13. PubMed ID: 25041872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
    Noor NM; Sheikh K; Somavarapu S; Taylor KMG
    Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P2X3 receptors contribute to transition from acute to chronic muscle pain.
    Jorge CO; de Azambuja G; Gomes BB; Rodrigues HL; Luchessi AD; de Oliveira-Fusaro MCG
    Purinergic Signal; 2020 Sep; 16(3):403-414. PubMed ID: 32766958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.